Walker Robert, Derrett Sarah, Campbell John, Marshall Mark R, Henderson Andrew, Schollum John, Williams Sheila, McNoe Bronwen
BMC Nephrol. 2013 Aug 14;14:175. doi: 10.1186/1471-2369-14-175.
The number of elderly people over the age of 65 commencing dialysis in NZ has increased by almost 400% in the past decade. Few data are available about health related outcomes and survival on dialysis in the elderly to help the individual, their family, clinicians and health planners with decision-making.
METHODS/DESIGN: This study will provide the first comprehensive longitudinal survey of health-related quality of life (HRQOL) and other patient centred outcomes for individuals aged ≥65 years on, or eligible for, dialysis therapy and will link these data to survival outcomes. Data collected by yearly structured interviews with participants will be linked to co-morbidity data, health service use, and laboratory information collected from health records, and analysed with respect to HRQOL and survival. The information obtained will inform the delivery of dialysis services in New Zealand and facilitate improved decision-making by individuals, their family and clinicians, about the appropriateness and impact of dialysis therapy on subsequent health and survival.
Results from this study will make possible more informed decision-making by future elderly patients and their families as they contemplate renal replacement therapy. Results will also allow health professionals to more accurately describe the impact of dialysis therapy on quality of life and outcomes for patients.
ACTRN12611000024943.
在过去十年中,新西兰开始接受透析治疗的65岁以上老年人数量增加了近400%。关于老年人透析的健康相关结局和生存率的数据很少,无法帮助个人、其家人、临床医生和卫生规划人员进行决策。
方法/设计:本研究将首次对65岁及以上正在接受或符合透析治疗条件的个体进行全面的纵向健康相关生活质量(HRQOL)及其他以患者为中心的结局调查,并将这些数据与生存结局相关联。通过每年与参与者进行结构化访谈收集的数据将与合并症数据、卫生服务使用情况以及从健康记录中收集的实验室信息相关联,并就HRQOL和生存情况进行分析。所获得的信息将为新西兰透析服务的提供提供参考,并促进个人、其家人和临床医生在透析治疗的适宜性及其对后续健康和生存的影响方面做出更好的决策。
本研究的结果将使未来的老年患者及其家人在考虑肾脏替代治疗时能够做出更明智的决策。结果还将使卫生专业人员能够更准确地描述透析治疗对患者生活质量和结局的影响。
ACTRN12611000024943。